Evidence map›Paper›PMID 35567502›Full record

ArticleFEBS open bio2022

ARL2 is required for homologous recombination repair and colon cancer stem cell survival.

Hani Lee, SeokGyeong Choi, Sojung Ha, Sukjoon Yoon, Woo-Young Kim

Open access · goldAbstract read
In one paragraph

Article in FEBS open bio, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Hani LeeCollege of Pharmacy, Sookmyung Women's University, Seoul, Korea.ORCID 0000-0002-3706-6906
SeokGyeong ChoiCollege of Pharmacy, Sookmyung Women's University, Seoul, Korea.
Sojung HaCollege of Pharmacy, Sookmyung Women's University, Seoul, Korea.
Sukjoon YoonDepartment of Biological Sciences, Sookmyung Women's University, Seoul, Korea.
Woo-Young KimCollege of Pharmacy, Sookmyung Women's University, Seoul, Korea.ORCID 0000-0002-2895-4995
Sookmyung Women's University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ARL2 regulates the dynamics of cytological components and is highly expressed in colon cancer tissues. Here, we report novel roles of ARL2 in the cell nucleus and colon cancer stem cells (CSCs). ARL2 is expressed at relatively low levels in K-RAS active colon cancer cells, but its expression is induced in CSCs. Depletion of ARL2 results in M phase arrest exclusively in non-CSC cultured cells; in addition, DNA break stress accumulates in CSCs leading to apoptosis. ARL2 expression is positively associated with the expression of all six RAD51 family genes, which are essential for homologous recombination repair (HRR). Furthermore, ARL2 is required for HRR and detected within chromatin compartments. These results demonstrate the requirement of ARL2 in colon CSC maintenance, which possibly occurs through mediating double-strand break DNA repair in the nucleus.

Indexed as

Colonic NeoplasmsDNA RepairGTP-Binding ProteinsNeoplastic Stem CellsRecombinational DNA RepairHumansRad51 RecombinaseARL2 protein, humanGTP-Binding ProteinsRad51 RecombinaseARL2cancer stem cellscolon cancerdouble-strand repairhomologous recombination repair

Identifiers

PMID35567502
PMCPMC9340879
OpenAlexW4280516205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.